馃攳
4 Glaring Signs of a Rally in The Forgotten BioTech Sector - Paul Mampilly - YouTube
Channel: Paul Mampilly
[0]
Hi there, it's Paul and this is your very
first, for me at least, edition of Bold
[7]
Profits Daily, and this week I want to
tell you about an incredible opportunity
[15]
in a sector that people have given up
for dead and because of that they're
[21]
missing signs that this incredibly hot
sector is about it take off, and I can
[28]
tell you from past history now when this
sector takes off, people make big money
[33]
fast, so this is a really, really exciting
opportunity. So what am I talking about,
[41]
the sector I'm talking about is
biotechnology. Those of you can think
[46]
back to 2013 and 14 and 2015 this was an
incredibly hot sector.There were stocks
[54]
that made people hundreds of percent in
some cases even thousands of percent, and
[61]
there have been things that have been
going on for the last few months that
[66]
have been telling me that the insiders
have been nibbling and accumulating
[71]
biotech stocks, big stocks, small stocks,
pushing things up ever so slowly so most
[77]
of you won't notice, and it's all now
suddenly coming out into the open and
[85]
you might have heard that just this week
Bristol-Myers has agreed to buy another
[93]
large biotech company called Celgene for
$74 billion. If you were in
[99]
Celgene you made 30 percent overnight,
just like that,
[104]
and I believe that's a good deal so
people that own Bristol-Myers I believe
[109]
are going to do well because I believe
Bristol-Myers stock is actually going to
[114]
benefit from this deal. Another deal that
happened earlier in December was when
[119]
another large pharmaceutical company
GlaxoSmithKline bought a biotech call to
[126]
Tesaro for $4 billion in that case
[129]
Tesaro's shares rocketed up by 70%
again, rocket fast in a day, and there's
[138]
also other small details that are really
important for you to know, which is that
[142]
even though it's been this fear or panic
and worry in the stock market
[148]
biotechs have actually been doing okay
and I measure that by the fact that Wall
[155]
Street has been able to sell 51 IPOs to
investors while all this panic and gloom
[161]
has been going on including one mega deal for a company called Moderna where they
[166]
did it for $600 million in other
words the big money wants to play in
[173]
biotech. The deal between Bristol-Myers
and Celgene tells you that the deal
[178]
between GlaxoSmithKline and Tesaro
tells you that, the 51 IPOs tells you
[183]
that, the deal from Moderna tells you
that, and that means it's time for you to
[190]
get in right now into biotech, and the
easiest way to get into biotech is to
[198]
own an ETF, and you can choose between
any number of biotech ETFs, however I'm
[206]
going to show you a very unique ETF that
will give you more exposure to the small
[214]
names like Tesaro that can rocket
up if somebody buys them, that can rocket
[219]
up if they have a good result in one of
their clinical trials, or if there is an
[224]
announcement in one of their drugs or
even a company that has similar drug, and
[228]
the ticker symbol for that ETF is XBI
and this is the Nasdaq biotechnology ETF
[237]
and the secret sauce that makes this ETF
move more than others is because it has
[246]
an equal weighted strategy. In other
words, it puts equal weights into all of
[250]
the companies - that's different than
other ETFs which base it on the stock
[258]
market value, in other words the bigger
companies,
[260]
higher weights, and the smaller companies get really small weights, obviously if
[265]
you're equal weighted, if a small company
goes up a lot that ETF is going to jump
[271]
higher so XBI, which is the Nasdaq
biotechnology ETF. Now this is obviously
[278]
a shameless plug - nonetheless I want to
tell you that, if you really want the
[284]
names, the single names, that can really
shoot higher 300 500 700 even 1000% like
[291]
they did the last bull market, you should
look at the stocks that we have in one
[297]
of my services Extreme Fortunes. There we pick the tiny small biotechs that can
[302]
really rocket higher. So that's my Bold
Profits Daily for you this week - buy into
[309]
biotech right now using XBI which is the
ticker symbol for the ETF that I would
[316]
tell you to buy into to get in on the
coming bull market in biotech, and also
[322]
check out my Extreme Fortunes service
where we have a lot of very, very small,
[329]
ready-to-go-up-a-lot stocks in the
biotech sector. So I'll have another Bold
[336]
Profits Daily for you next week. Until
then, this is Paul saying bye.
Most Recent Videos:
You can go back to the homepage right here: Homepage